NIH Awards $3.3M to Ribeiro Dasilva and Fillingim
The clinical trial goal is to determine whether PBM offers an alternative treatment for individuals living with painful TMDs - a treatment that will reduce pain for patients while also reducing the use of opioids in pain management.